Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Working Capital Changes (2023 - 2025)

Mangoceuticals' Other Working Capital Changes history spans 3 years, with the latest figure at -$17950.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 11.92% year-over-year to -$17950.0; the TTM value through Sep 2025 reached -$69340.0, up 60.72%, while the annual FY2024 figure was -$63717.0, 12.32% down from the prior year.
  • Other Working Capital Changes for Q3 2025 was -$17950.0 at Mangoceuticals, down from -$17596.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $100499.0 in Q3 2023 and bottomed at -$129363.0 in Q4 2023.
  • The 3-year median for Other Working Capital Changes is -$16545.0 (2024), against an average of -$15748.9.
  • The largest YoY upside for Other Working Capital Changes was 87.21% in 2024 against a maximum downside of 178.91% in 2024.
  • A 3-year view of Other Working Capital Changes shows it stood at -$129363.0 in 2023, then soared by 87.21% to -$16545.0 in 2024, then decreased by 8.49% to -$17950.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Other Working Capital Changes are -$17950.0 (Q3 2025), -$17596.0 (Q2 2025), and -$17249.0 (Q1 2025).